Health Care

International Business Machines said on Thursday it plans to acquire Truven Health Analytics, a provider of healthcare data and analytics, for $2.6 billion, marking its fourth major health data-related deal in the past year.

Community Health Systems shares were under pressure, after the No.2 U.S. for-profit hospital operator posted a surprise quarterly loss Monday after the close.

Regeneron Pharmaceuticals reported a weaker-than-expected profit for the first time in four quarters and forecast slowing sales growth for its blockbuster eye drug this year.

Edwards Lifesciences raised its full-year earnings forecast, anticipating stronger sales of its artificial heart valves.

Dow component Pfizer reported an adjusted 4Q profit of $0.53 per share, topping the estimate for $0.52. Revenue for the drugmaker came in at $14 billion, also beating the estimate for $13.56 billion.

Drugmaker Abbott Laboratories said it would acquire Alere for $5.8 billion to boost its global diagnostics presence.

Health insurer Aetna reported a 38 percent rise in quarterly profit, helped by strong performance in its government business that sells Medicare and Medicaid plans.

Generic drug maker Actavis agreed to acquire Warner Chilcott in an all-stock deal that values the Irish company at roughly $5 billion.

Campbell Soup revealed stronger-than-expected third-quarter earnings and boasted a full-year outlook above analyst forecasts on Monday.

The $100 billion of stimulus money that boosted funding for Medicaid will run out at the end of June, leaving states in a tough spot.